Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Perel

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemiaG Michel, J Landman-Parker, M F Auclerc, et al.
British Journal of Cancer|July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, J Michon, D Plantaz, et al.
Leukemia|August 27, 2005
Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative GroupY Perel, A Auvrignon, T Leblanc, et al.
Haematologica|January 14, 2011
New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 childrenNathalie Aladjidi, Guy Leverger, Thierry Leblanc, et al.
Hematology and Cell Therapy|April 1, 1996
Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)G Michel, A Baruchel, M D Tabone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection--a Study of the French Society of Pediatric OncologyB Pellegrino, M J Terrier-Lacombe, O Oberlin, et al.
British Journal of Cancer|January 8, 2004
Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemiaN Jourdan-Da Silva, Y Perel, F Méchinaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie PédiatriqueH Rubie, O Hartmann, J Michon, et al.
Bone Marrow Transplantation|September 6, 2016
Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA studyA Sirvent, P Auquier, C Oudin, et al.
Bone Marrow Transplantation|June 11, 2013
Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie CellulaireC Paillard, E Rochette, P Lutz, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemiaG Michel, J Landman-Parker, M F Auclerc, et al.
British Journal of Cancer|July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, J Michon, D Plantaz, et al.
Leukemia|August 27, 2005
Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative GroupY Perel, A Auvrignon, T Leblanc, et al.
Haematologica|January 14, 2011
New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 childrenNathalie Aladjidi, Guy Leverger, Thierry Leblanc, et al.
Hematology and Cell Therapy|April 1, 1996
Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)G Michel, A Baruchel, M D Tabone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection--a Study of the French Society of Pediatric OncologyB Pellegrino, M J Terrier-Lacombe, O Oberlin, et al.
British Journal of Cancer|January 8, 2004
Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemiaN Jourdan-Da Silva, Y Perel, F Méchinaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie PédiatriqueH Rubie, O Hartmann, J Michon, et al.
Bone Marrow Transplantation|September 6, 2016
Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA studyA Sirvent, P Auquier, C Oudin, et al.
Bone Marrow Transplantation|June 11, 2013
Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie CellulaireC Paillard, E Rochette, P Lutz, et al.
Pageof 7